Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In Vivo
Author(s) -
Kalkidan Bishu,
Nazha Hamdani,
Selma F. Mohammed,
Martina Krüger,
Tomohito Ohtani,
Ozgur Ogut,
Frank V. Brozovich,
John C. Burnett,
Wolfgang A. Linke,
Margaret M. Redfield
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.048520
Subject(s) - medicine , sildenafil , cardiology , titin , natriuretic peptide , troponin i , diastole , phospholamban , endocrinology , atrial natriuretic peptide , phosphorylation , myocyte , heart failure , blood pressure , sarcomere , myocardial infarction , chemistry , biochemistry
In vitro studies suggest that phosphorylation of titin reduces myocyte/myofiber stiffness. Titin can be phosphorylated by cGMP-activated protein kinase. Intracellular cGMP production is stimulated by B-type natriuretic peptide (BNP) and degraded by phosphodiesterases, including phosphodiesterase-5A. We hypothesized that a phosphodiesterase-5A inhibitor (sildenafil) alone or in combination with BNP would increase left ventricular diastolic distensibility by phosphorylating titin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom